From July 1, 2022 to September 30, 2022, the company has repurchased 16,117,100 shares, representing 0.86% for CNY 183.6 million. With this, the company has completed the repurchase of 36,138,098 shares, representing 1.94% for CNY 425.67 million under the buyback announced on April 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.19 CNY | -1.92% | -0.24% | +16.83% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.83% | 4.4B | |
+20.77% | 72.16B | |
-0.97% | 23.88B | |
+8.25% | 8.35B | |
+5.13% | 8.29B | |
-19.42% | 8.18B | |
+5.56% | 4.81B | |
-1.83% | 4B | |
-1.65% | 3.92B | |
+26.97% | 3.79B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.